Navigation Links
Barry D. Rutherford, M.D. presented with Master Clinical Operator Award at TCT 2012
Date:10/26/2012

MIAMI, FL OCTOBER 26, 2012 Barry D. Rutherford, MD, a world renowned interventional cardiologist, was presented the TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award in a ceremony held today during the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF). The award is given each year to a physician who has advanced the field of interventional cardiovascular medicine through technical excellence and innovation.

An early mentor of Dr. Hartzler at the Mayo Clinic in Rochester, Minnesota, and later a colleague of his at the Saint Luke's Mid America Heart Institute in Kansas City, Missouri, Dr. Rutherford is known for his expertise in the development of techniques for direct balloon angioplasty in acute myocardial infarction and multi-vessel angioplasty. Among his current research interests are the development of new procedures for the treatment of chronic total occlusions in coronary arteries and for the management of acute myocardial infarction.

Dr. Rutherford has also devoted much of his career to physician training and education, teaching countless numbers of physicians over the years. In addition to serving as the principal investigator of a number of clinical trials, Dr. Rutherford has authored more than 200 abstracts and publications in peer reviewed journals and has delivered more than 230 invited lectures around the world.

TCT Directors, Gregg W. Stone, MD and Martin B. Leon, MD jointly presented the award, which recognizes technical skill and expertise. Dr. Leon is the Founder of CRF and Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. Dr. Stone is Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. Both serve as Co-Directors of the Medical Research and Education Division at CRF, and direct the annual TCT scientific sessions.

"Dr. Rutherford is highly deserving of the TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award," said Dr. Stone. "His long-standing commitment to primary PCI and multivessel intervention, and technical expertise in CTO angioplasty have helped to expand the field of interventional cardiovascular medicine and provided physicians with new, more effective ways to treat patients."

"Dr. Rutherford continues to develop innovative techniques and devices for patients with cardiovascular disease, in addition to serving as mentor and teacher to the next generation of interventional cardiologists," Dr. Leon added.

Dr. Rutherford is currently the Director of the Interventional Cardiology Research Program at St. Luke's Mid America Heart Institute in Kansas City, Missouri. He is also a Professor of Medicine at the University of Missouri in Kansas City. Prior to his current position, Dr. Rutherford was consulting cardiologist at the Mayo Clinic, and Director of the Coronary Care Unit at St. Mary's Hospital in Rochester, Minnesota where he initiated research into pulmonary artery pressure during acute myocardial infarction and computer assisted patient records in the intensive care unit.

Dr. Rutherford earned his medical degree at Otago University Medical School (Dunedin, New Zealand) in 1963 and completed his residency training at the Mayo Graduate School of Medicine and Mayo Foundation for Cardiovascular Diseases.


'/>"/>
Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. Renu Virmani, M.D. presented with 2012 TCT Career Achievement Award
2. Results of the AIDA STEMI MRI sub-study presented at TCT 2012
3. Results of the PC trial presented at TCT 2012
4. Results of the POSEIDON trial presented at TCT 2012
5. 1-year results of ADAPT-DES presented at TCT 2012
6. CRF announces late breaking trials and first report investigations to be presented at TCT 2012
7. New clinical guidelines for managing hypothyroid disease presented in Thyroid Journal
8. Research presented at TCT 2012 will have significant impact on interventional cardiology
9. Typical IBD patients not represented in research studies
10. Robotic surgery outcomes data presented at head and neck cancer annual meeting
11. Special issue of Cell Transplantation features research presented at IANR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... , ... December 03, 2016 , ... While James Earl ... serving as host for in a show called "Front Page". One of the forthcoming ... years, breast cancer rates have plummeted in large part due to early detection. Like ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to ... advantage of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser ... of age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and ... will speak at the American Conference Institute’s 21st Drug & Medical Device Litigation ... Lead Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than 100 business, civic, ... to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This inaugural event, ... and operating support to UNCF-member institutions, including Miles College, Oakwood University, Tuskegee University, ...
(Date:12/2/2016)... ... , ... The annual time frame to change Medicare health and prescription drug ... 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current plan to ... make changes during this period order for their new policy to go into effect ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... 2016  Results from the Phase II SUSTAIN study ... reduced the median annual rate of sickle cell-related pain ... 2.98, p=0.010) in patients with or without hydroxyurea therapy ... being featured in the official press briefing at the ... Meeting and presented during the Plenary Scientific Session tomorrow ...
(Date:12/2/2016)... December 2, 2016 - bioLytical lanza el INSTI HIV ... la OMS     Continue Reading ... ... , , bioLytical ... anunciado hoy que está expandiendo el lanzamiento de su INSTI HIV Self Test ...
(Date:12/2/2016)... December 2, 2016 According to the ... Market Study on Automated Endoscope Reprocessors: Single Basin Automated Endoscope ... 8.6% Between 2016 and 2024 " the global automated endoscope reprocessors market was ... to expand at a CAGR of 7.2% during an eight-year ... 1,367.6 Mn by 2024. ...
Breaking Medicine Technology: